Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1

Abstract Objectives The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating adrenergic innervation with disease progression media...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda deHoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:BJUI Compass
Subjects:
active surveillance
atenolol
beta adrenergic blockers
beta adrenergic receptors
prostate cancer
Online Access:https://doi.org/10.1002/bco2.441
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/bco2.441

Similar Items